The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.
ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.
Polymer-Based Technology to Drive the Branched Stent Grafts Market
Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.
Growing Vascular Surgeries Boost Demand
The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.
However, the poor durability of metallic grafts will impede the growth during the forecast period.
Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.
The demand for biocompatible stent grafts will go up as it has good durability.
Advancements in medical technology are helping with diagnostic and therapeutic treatments on various diseases; this leads to a lowering of mortality rates. This will lead to the growth of this market during the forecast period.
The growing demand for minimally invasive procedures will drive the global branched stent market to expand in the coming years.
Regionally, the North America Branched Stent Grafts market is anticipated to hold the largest share in this market during the forecast period. The growth can be ascribed to the strong presence of major players in the region, as well as technologically advanced health infrastructure. The increasing prevalence of coronary artery diseases and the rising number of geriatric populations in North America will also be driving the growth of this market. Europe is another promising region for these products, despite tough competition from Asia-Pacific.
The Asia Pacific seems like a favourable location, the reason being an increased incidence rate of coronary artery diseases in the region due to lifestyle diseases; medical tourism and higher spending on healthcare will also drive the global branched stent market during the forecast years.
The players in the global branched stent-grafts market include-
- Cook Medical
- Eucatech AG
- Merit Medical Systems
- Endocor GmbH
- Boston Scientific Corp.
- Terumo Corp.
- Cardinal Health (Cordis)
ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.
- The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.
- The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.
- Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.
Type Outlook (Revenue, USD Billion)
- Wire & Mesh
- Iliac Stent
Application Outlook (Revenue, USD Billion)
- The Netherlands
Middle East & Africa
- South Africa
- Saudi Arabia